Does HIV serostatus affect outcomes of dually diagnosed opiate dependents in residential treatment?

Epidemiologia e Psichiatria Sociale

Volumn 17, Issue 1, 2008, Pages 77-81

  Carrà, Giuseppe ^a   Montomoli, Cristina ^b   Monti, Maria Cristina ^b   Clerici, Massimo ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b UNIVERSITY OF PAVIA   (Italy)

^c UNIVERSITY OF MILANO BICOCCA   (Italy)

Author keywords

Mental disorders; Opiate dependence; Seropositivity; Therapeutic community

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; HEALTH PROGRAM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; OPIATE ADDICTION; RECURRENT DISEASE;

EID: 41349094626     PISSN: 1121189X     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1121189x00002712     Document Type: Article

References (33)

1. American Psychiatric Association (1994). Diagnostic and Statistical Manual of Mental Disorders, 4th ed. American Psychiatric Association: Washington DC.
2. Baigent M.F. (2003). Physical complications of substance abuse: what the psychiatrist needs to know. Current Opinion in Psychiatry 16, 291-296.
3. Bizzarri J.V., Rucci P., Casalboni D., Randi S., Tattini M., Girelli M., Pojer F. & Sbrana A. (2007). Substance use and psychiatric symptoms in subjects referred to the Drug Addiction Services by the prefecture. Epidemiologia e Psichiatria Sociale 16, 73-78.
4. Carrà G. & Clerici M. (2003). The Italian Association on Addiction Psychiatry (SIP Dip), formerly The Italian Association on Abuse and Addictive Behaviours. Addiction 98, 1039-1042.
5. Carrà G. & Clerici M. (2006). Dual diagnosis: policy and practice in Italy. American Journal on Addictions 15, 144-149.
6. Carrà G., Scioli R., Monti M.C. & Marinoni A. (2006). Severity profiles of substance-abusing patients in Italian community addiction facilities: influence of psychiatric concurrent disorders. European Addiction Research 12, 96-101.
7. Centers for Disease Control and Prevention (CDC) (1999). Community-level HIV intervention in 5 cities: Final outcome data from the CDC AIDS Community Demonstration Projects. American Journal of Public Health 89, 336-345.
8. Clayton D. & Hills M. (1993). Statistical Models in Epidemiology. Oxford University Press: Oxford.
9. Crawford V., Crome I.B. & Clancy C. (2003). Co-existing problems of mental health and substance misuse (Dual Diagnosis): a literature review. Drugs: Education, Prevention and Policy 10, Suppl. 1, 1-74.
10. Crome I.B. (2000). Dissemination of current treatment research findings to the profession, policy makers and patients-whose responsibility is it? Addiction 95, 1767-1769.
11. De Leon G., Sacks S., Staines G. & McKendrick K. (2000). Modified therapeutic community for homeless mentally ill chemical abusers: treatment outcomes. American Journal of Drug and Alcohol Abuse 26, 461-480.
12. Egelko S., Galanter M., Dermatis H., Jurewicz E., Jamison A., Dingle S. & De Leon G. (2002). Improved psychological status in a modified therapeutic community for homeless MICA men. Journal of Addictive Diseases 21, 75-92.
13. First M.B., Williams J.B., Gibbon M. & Spitzer R.L. (1997a). Structured Clinical Interview for DSM-IV AXIS I Disorders, Clinician Version. American Psychiatric Press: Washington.
14. First M.B., Williams J.B. & Spitzer R.L. (1997b). Structured Clinical Interview for DSM-IV AXIS II Personality Disorders. American Psychiatric Press: Washington.
15. Gaughwin M., Solomon P. & Ali R. (1998). Correlates of retention on the South Australian Methadone Program 1981-91. Australian and New Zealand Journal of Public Health 22, 771-776.
16. Goldsmith H.F., Wagenfeld M.O., Manderscheid R.W. & Stiles D.J. (1996). Geographical distribution of organized mental health services in 1983 and 1990. In Mental Health, United States, 1996 (ed. R.W. Manderscheid and M.A. Sonnenschein), pp. 154-167, DHHS Publication No. SMA 96-3098. Substance Abuse and Mental Health Services Administration, Center for Mental Health Services: Rockville, MD.
17. Gonzalez I., Rosenthal M.S., Bigler M.O., Alper K. & Geringer W. (1994). HIV antibody testing and client retention in the therapeutic Community. A preliminary report of Phoenix House. Journal of Substance Abuse Treatment 11, 481-488.
18. Hoff R.A., Beam-Goulet J. & Rosenheck R.A. (1997). Mental disorder as a risk factor for human immunodeficiency virus infection in a sample of veterans. Journal of Nervous and Mental Disease 185, 556-560.
19. Hunt G.E., Bergen J. & Bashir M. (2002). Medication compliance and comorbid substance abuse in schizophrenia: impact on community survival 4 years after a relapse. Schizophrenia Research 54, 253-264.
20. Kelley J.L. & Petty N.M. (2000). HIV risk behaviors in male substance abusers with and without antisocial personality disorder. Journal of Substance Abuse Treatment 19, 59-66.
21. Kingree J.B., Glasford M.T. & Jones-Allen M. (1997). A comparison of HIV-positive and HIV-negative crack users enrolled in a residential addiction treatment program. American Journal of Drug and Alcohol Abuse 23, 569-580.
22. Margolese H.C., Malchy L., Negrete J.C., Tempier R. & Gill K. (2004). Drug and alcohol use among patients with schizophrenia and related psychoses: levels and consequences. Schizophrenia Research 67, 157-166.
23. Meade C.S. & Sikkema K.J. (2005). HIV risk behavior among adults with severe mental illness: a systematic review. Clinical Psychology Review 25, 433-457.
24. Nuttbrock L.A., Rahav M., Rivera J.J., Ng-Mak D.S. & Link B.G. (1998). Outcomes of homeless mentally ill chemical abusers in community residences and a therapeutic community. Psychiatric Services 49, 68-76.
25. Pani P.P., Trogu E., Contu P., Agus A. & Gessa G.L. (1997). Psychiatric severity and treatment response in a comprehensive methadone maintenance treatment program. Drug and Alcohol Dependence 48, 119-126.
26. Sacks S., Sacks J.Y. & De Leon G. (1999). Treatment for MICAs: design and implementation of the modified TC. Journal of Psychoactive Drugs 31, 19-30.
27. Schilling R.F., El-Bassel N., Schinke SP., Gordon K. & Nichols S. (1991). Building skills of recovering women drug users to reduce heterosexual AIDS transmission. Public Health Reports 106, 297-304.
28. Schlesinger M. & Dorwart R.A. (1992). Falling between the cracks: Failing national strategies for the treatment of substance abuse. Daedalus 121, 195-237.
29. Sikkema K.J., Meade C.S., Doughty-Berry J.D., Zimmerman S.O., Kloos B. & Snow D.L. (2007). Community-level HIV prevention for persons with severe mental illness living in supportive housing programs: a pilot intervention study. Journal of Prevention & Intervention in the Community 33, 121-135.
30. Stata Corporation. (2003). Stata Statistical Software: Release 8.0. Stata Corporation: College Station, TX.
31. Weiser S.D., Wolfe W.R. & Bangsberg D.R. (2004). The HIV epidemic among individuals with mental illness in the United States. Current HIV/AIDS Reports 1, 186-192.
32. Winett R.A., Anderson E.S., Desiderata L.L., Solomon L.J., Perry M., Kelly J.A., Sikkema K.J., Roffman R.A., Norman A.D., Lombard D.N. & Lombard T.N. (1995). Enhancing social diffusion theory as a basis for prevention intervention: A conceptual and strategic framework. Applied and Preventive Psychology 4, 233-245.
33. Zisook S., Peterkin J., Goggin K.J., Sledge P., Atkinson J.H. & Grant I. (1998). Treatment of major depression in HIV-seropositive men. HIV Neurobehavioral Research Center Group. Journal of Clinical Psychiatry 59, 217-224.